Overview
Regeneron's strategic investment division, focused on life sciences and gene editing.
Connected profiles
Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
再生元制药（Regeneron）旗下战略投资部门，聚焦生命科学与基因编辑。